Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 6725749
[patent_doc_number] => 20030208061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-06
[patent_title] => 'Labeled oligonucleotides, methods for making same, and compounds useful therefor'
[patent_app_type] => new
[patent_app_number] => 09/823031
[patent_app_country] => US
[patent_app_date] => 2001-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 19965
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20030208061.pdf
[firstpage_image] =>[orig_patent_app_number] => 09823031
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/823031 | Labeled oligonucleotides, methods for making same, and compounds useful therefor | Mar 29, 2001 | Issued |
09/806440 | Methods and compositions for inducing differentiation and apotosis in cells tha overexpess the notch protein | Mar 29, 2001 | Abandoned |
Array
(
[id] => 6885099
[patent_doc_number] => 20010039263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-08
[patent_title] => 'Chimeric oligonucleotides and the use thereof'
[patent_app_type] => new
[patent_app_number] => 09/817387
[patent_app_country] => US
[patent_app_date] => 2001-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5178
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20010039263.pdf
[firstpage_image] =>[orig_patent_app_number] => 09817387
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/817387 | Chimeric oligonucleotides and the use thereof | Mar 25, 2001 | Abandoned |
Array
(
[id] => 6537401
[patent_doc_number] => 20020137162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Antisense oligonucleotide inhibition of specific histone deacetylase isoforms'
[patent_app_type] => new
[patent_app_number] => 09/817538
[patent_app_country] => US
[patent_app_date] => 2001-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 12260
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137162.pdf
[firstpage_image] =>[orig_patent_app_number] => 09817538
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/817538 | Antisense oligonucleotide inhibition of specific histone deacetylase isoforms | Mar 25, 2001 | Abandoned |
Array
(
[id] => 6898803
[patent_doc_number] => 20010046968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-29
[patent_title] => 'Opioid growth factor modulates angiogenesis'
[patent_app_type] => new
[patent_app_number] => 09/815069
[patent_app_country] => US
[patent_app_date] => 2001-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6131
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20010046968.pdf
[firstpage_image] =>[orig_patent_app_number] => 09815069
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/815069 | Opioid growth factor modulates angiogenesis | Mar 21, 2001 | Abandoned |
09/623307 | Composition for transporting negatively charged substances | Mar 20, 2001 | Abandoned |
Array
(
[id] => 1083149
[patent_doc_number] => 06833450
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-12-21
[patent_title] => 'Phosphite ester oxidation in nucleic acid array preparation'
[patent_app_type] => B1
[patent_app_number] => 09/810434
[patent_app_country] => US
[patent_app_date] => 2001-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 8947
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/833/06833450.pdf
[firstpage_image] =>[orig_patent_app_number] => 09810434
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/810434 | Phosphite ester oxidation in nucleic acid array preparation | Mar 14, 2001 | Issued |
Array
(
[id] => 1104418
[patent_doc_number] => 06811975
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-11-02
[patent_title] => 'Phosphorothioate oligonucleotides having modified internucleoside linkages'
[patent_app_type] => B2
[patent_app_number] => 09/805630
[patent_app_country] => US
[patent_app_date] => 2001-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11625
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 279
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/811/06811975.pdf
[firstpage_image] =>[orig_patent_app_number] => 09805630
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/805630 | Phosphorothioate oligonucleotides having modified internucleoside linkages | Mar 13, 2001 | Issued |
Array
(
[id] => 6432021
[patent_doc_number] => 20020127556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'DNA encoding human Cid2'
[patent_app_type] => new
[patent_app_number] => 09/800244
[patent_app_country] => US
[patent_app_date] => 2001-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10332
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20020127556.pdf
[firstpage_image] =>[orig_patent_app_number] => 09800244
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/800244 | DNA encoding human Cid2 | Mar 5, 2001 | Abandoned |
Array
(
[id] => 6987261
[patent_doc_number] => 20010036927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-01
[patent_title] => 'Glycerolipid compounds useful for the transfer of an active substance into a target cell'
[patent_app_type] => new
[patent_app_number] => 09/796650
[patent_app_country] => US
[patent_app_date] => 2001-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16077
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20010036927.pdf
[firstpage_image] =>[orig_patent_app_number] => 09796650
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/796650 | Glycerolipid compounds useful for the transfer of an active substance into a target cell | Mar 1, 2001 | Issued |
Array
(
[id] => 6801604
[patent_doc_number] => 20030096769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders'
[patent_app_type] => new
[patent_app_number] => 09/791196
[patent_app_country] => US
[patent_app_date] => 2001-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 15327
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20030096769.pdf
[firstpage_image] =>[orig_patent_app_number] => 09791196
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/791196 | Method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders | Feb 22, 2001 | Abandoned |
Array
(
[id] => 6660162
[patent_doc_number] => 20030134806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Method and reagent for the inhibition of grid'
[patent_app_type] => new
[patent_app_number] => 09/792818
[patent_app_country] => US
[patent_app_date] => 2001-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 39516
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20030134806.pdf
[firstpage_image] =>[orig_patent_app_number] => 09792818
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/792818 | Method and reagent for the inhibition of grid | Feb 22, 2001 | Abandoned |
Array
(
[id] => 1093518
[patent_doc_number] => 06825341
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-11-30
[patent_title] => 'Process for preparing functionalized polyalkyleneimines, compositions containing them and uses thereof'
[patent_app_type] => B2
[patent_app_number] => 09/783981
[patent_app_country] => US
[patent_app_date] => 2001-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4917
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/825/06825341.pdf
[firstpage_image] =>[orig_patent_app_number] => 09783981
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/783981 | Process for preparing functionalized polyalkyleneimines, compositions containing them and uses thereof | Feb 15, 2001 | Issued |
Array
(
[id] => 6433852
[patent_doc_number] => 20020127714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Inhibitors of alternative alleles of genes encoding products that mediate cell response to environmental changes'
[patent_app_type] => new
[patent_app_number] => 09/782837
[patent_app_country] => US
[patent_app_date] => 2001-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 31774
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20020127714.pdf
[firstpage_image] =>[orig_patent_app_number] => 09782837
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/782837 | Inhibitors of alternative alleles of genes encoding products that mediate cell response to environmental changes | Feb 13, 2001 | Abandoned |
09/762992 | Nucleotide and/or amino-acid sequence controlling the expression of a xylanase promoter-operator nucleotide sequence | Feb 13, 2001 | Abandoned |
09/778855 | Mass spectrometry to assess dna sequence polymorphisms | Feb 7, 2001 | Abandoned |
Array
(
[id] => 6016026
[patent_doc_number] => 20020102694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Nucleozymes with endonuclease activity'
[patent_app_type] => new
[patent_app_number] => 09/781902
[patent_app_country] => US
[patent_app_date] => 2001-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15762
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20020102694.pdf
[firstpage_image] =>[orig_patent_app_number] => 09781902
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/781902 | Nucleozymes with endonuclease activity | Feb 7, 2001 | Abandoned |
Array
(
[id] => 1236355
[patent_doc_number] => 06689858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-02-10
[patent_title] => 'Halogen-modified silicon, surfaces'
[patent_app_type] => B2
[patent_app_number] => 09/770885
[patent_app_country] => US
[patent_app_date] => 2001-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 9782
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/689/06689858.pdf
[firstpage_image] =>[orig_patent_app_number] => 09770885
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/770885 | Halogen-modified silicon, surfaces | Jan 25, 2001 | Issued |
Array
(
[id] => 7079704
[patent_doc_number] => 20010041965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-15
[patent_title] => 'Polymorphism detection utilizing clustering analysis'
[patent_app_type] => new
[patent_app_number] => 09/764337
[patent_app_country] => US
[patent_app_date] => 2001-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5076
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20010041965.pdf
[firstpage_image] =>[orig_patent_app_number] => 09764337
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/764337 | Polymorphism detection utilizing clustering analysis | Jan 15, 2001 | Issued |
09/758063 | Fumonisin detoxification compositions and methods | Jan 9, 2001 | Abandoned |